Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice (Q40846016)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice (English)

1 reference

Europe PubMed Central

24 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A R Koippallil Gopalakrishnan

1

1 reference

Europe PubMed Central

24 September 2017

H Pandit

2

1 reference

Europe PubMed Central

24 September 2017

S M Metkari

3

1 reference

Europe PubMed Central

24 September 2017

N Warty

4

1 reference

Europe PubMed Central

24 September 2017

T Madan

5

1 reference

Europe PubMed Central

24 September 2017

publication date

18 March 2016

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

23

1 reference

Europe PubMed Central

24 September 2017

7

1 reference

Europe PubMed Central

24 September 2017

580-591

1 reference

Europe PubMed Central

24 September 2017

https://scigraph.springernature.com/pub.10.1038/gt.2016.30

0 references

Novel agents for the medical treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

MicroRNAs and angiogenesis in endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Antiangiogenic therapies in endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Antiangiogenesis therapy for endometriosis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Peripheral biomarkers of endometriosis: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor I.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Mesenchymal stem cells: potential in treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Stem cells and the pathogenesis of endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Anti-angiogenic treatment strategies for the therapy of endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Antiangiogenic agents are effective inhibitors of endometriosis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Investigation of immunomodulatory properties of human Wharton's Jelly-derived mesenchymal stem cells after lentiviral transduction.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Improved nude mouse models for green fluorescence human endometriosis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Matrix metalloproteinases and endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Theories on the pathogenesis of endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.30

21 January 2018

Angiogenesis as a therapeutic target in endometriosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor gene polymorphisms and the risk of endometriosis: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between endometriosis and hyperprolactinemia in infertile women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stem cell and endometriosis: new knowledge may be producing novel therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated vascular endothelia growth factor-A in the serum and peritoneal fluid of patients with endometriosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engineering mesenchymal stem cells for regenerative medicine and drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/26990775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/GT.2016.30

1 reference

Europe PubMed Central

24 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40846016&oldid=1908557362"